You are here



The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

30 September 2015

New WHO guidelines recommending HIV treatment for all

World Health Organisation releases new guidelines recommending all people living with HIV receive antiretroviral treatment, regardless of CD4 count.

15 September 2015

Progress in reducing perinatal HIV infection in Asia

New HIV infections among children in Asia have fallen by over 25% in fifteen years thanks to improved HIV testing and treatment for pregnant women.

10 September 2015

Workplace HIV treatment programmes have significant benefits

Company-provided antiretroviral treatment (ART) programmes are found to be highly cost-effective in settings with a high HIV prevalence.

28 May 2015

Major treatment trial concludes time is of the essence

A large international trial has overwhelmingly concluded that the health of people living with HIV considerably benefits from starting treatment early. It is widely acknowledged that giving antiretrovirals (ARVs) to HIV positive people before their CD4 count – a measure of the immune system – drops too low, makes treatment more effective. This study provides crucial new evidence that could be a game-changer in the delivery of HIV treatment around the world.

07 May 2015

Implant could revolutionise HIV treatment

A new way of administering antiretroviral treatment could revolutionise the current way people living with HIV take treatment. A new subdermal implant has been proven to be effective in the first 40 days, according to research published in the journal Antimicrobial Agents and Chemotherapy.

15 April 2015

Rates of transmitted HIV drug resistance increased only slightly

Rates of transmitted HIV drug resistance in low- and middle-income countries most affected by HIV have only increased modestly, according to recently published research in PloS Medicine. The findings describe a low increase in sub-Saharan Africa and no increase in the prevalence of transmitted HIV drug resistance in South Asia and Southeast Asia. In fact, overall drug resistance prevalence varies widely, with a prevalence of 2.8% in sub-Saharan Africa compared to a much higher prevalence of 11.5% in North America.

02 April 2015

Early uptake of HIV treatment has doubled in the UK

Early uptake of HIV treatment among people living with HIV in the UK has more than doubled over a five-year period between 2008 and 2011. The new figures were recently presented at a meeting held by Public Health England last week, and reported in Aidsmap.

23 January 2015

People living with HIV in Peru protest against high treatment prices

People living with HIV in Peru have demanded the Minister of Health, Aníbal Velásquez Valdivia, to declare the need for antiretroviral medication a national interest, and to lift the monopoly on medication, making it possible to buy generic treatment at a much lower price. Currently the US pharmaceutical company Brystol-Myers-Squibb has a government monopoly on the provision of the antiretroviral treatment Atazanavir, meaning the government is unable to buy any other treatment brand.

15 January 2015

Research calls for start of HIV treatment within 12 months of infection

Emerging research suggests that starting antiretroviral treatment (ART) at a CD4 count of 500 cells/mm3– the current treatment initiation threshold – is inadequate for normalising the functioning of the immune system. Contributing to this knowledge, a study published in JAMA states that starting ART within 12 months of becoming HIV positive, regardless of whether CD4 count has dropped to 500 cells/mm3 or not, results in measureable and significant immunological benefits.